Your browser doesn't support javascript.
loading
Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta, Sofia; Maia-Moço, Leonardo; Estevão-Pereira, Helena; Sequeira, José Pedro; Vieira, Renata; Bartosch, Carla; Petronilho, Sara; Monteiro, Paula; Sousa, Ana; Baldaque, Inês; Rodrigues, Jéssica; Sousa, Hugo; Tavares, Fernando; Henrique, Rui; Jerónimo, Carmen.
  • Salta S; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Maia-Moço L; Doctoral Program in Molecular Pathology and Genetics, School of Medicine and Biomedical Sciences-University of Porto (ICBAS-UP), Porto, Portugal.
  • Estevão-Pereira H; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Sequeira JP; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Vieira R; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Bartosch C; Master Program in Oncology, School of Medicine and Biomedical Sciences-University of Porto (ICBAS-UP), Porto, Portugal.
  • Petronilho S; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Monteiro P; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Sousa A; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Baldaque I; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Rodrigues J; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences-University of Porto (ICBAS-UP), Porto, Portugal.
  • Sousa H; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.
  • Tavares F; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Henrique R; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences-University of Porto (ICBAS-UP), Porto, Portugal.
  • Jerónimo C; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
Int J Cancer ; 149(11): 1916-1925, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34460099

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Metilación de ADN / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Metilación de ADN / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article